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ABSTRACT

This dissertation is directed towards improving the state of art cardiac monitoring methods and
automatic diagnosis of cardiac anomalies through modern engineering approaches such as adaptive signal
processing, and machine learning methods. The dissertation will describe the invention and associated
methods of a cardiac rhythm monitor dubbed the Integrated Vectorcardiogram (iVCG). In addition, novel
machine learning approaches are discussed to improve diagnoses and prediction accuracy of cardiac
diseases.
It is estimated that around 17 million people in the world die from cardiac related events each
year. It has also been shown that many of such deaths can be averted with long-term continuous
monitoring and actuation. Hence, there is a growing need for better cardiac monitoring solutions.
Leveraging the improvements in computational power, communication bandwidth, energy efficiency and
electronic chip size in recent years, the Integrated Vectorcardiogram (iVCG) was invented as an answer to
this problem. The iVCG is a miniaturized, integrated version of the Vectorcardiogram that was invented
in the 1930s. The Vectorcardiogram provides full diagnostic quality cardiac information equivalent to that
of the gold standard, 12-lead ECG, which is restricted to in-office use due to its bulky, obtrusive form.
With the iVCG, it is possible to provide continuous, long-term, full diagnostic quality information, while
being portable and unobtrusive to the patient. Moreover, it is possible to leverage this ‘Big Data’ and
create machine learning algorithms to deliver better patient outcomes in the form of patient specific
machine diagnosis and timely alerts.
First, we present a proof-of-concept investigation for a miniaturized vectorcardiogram, the iVCG
system for ambulatory on-body applications that continuously monitors the electrical activity of the heart
in three dimensions. We investigate the minimum distance between a pair of leads in the X, Y and Z axes
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such that the signals are distinguishable from the noise. The target dimensions for our prototype iVCG are
3x3x2 cm and based on our experimental results we show that it is possible to achieve these dimensions.
Following this, we present a solution to the problem of transforming the three VCG component
signals to the familiar 12-lead ECG for the convenience of cardiologists. The least squares (LS) method is
employed on the VCG signals and the reference (training) 12-lead ECG to obtain a 12x3 transformation
matrix to generate the real-time ECG signals from the VCG signals.
The iVCG is portable and worn on the chest of the patient and although a physician or trained
technician will initially install it in the appropriate position, it is prone to subsequent rotation and
displacement errors introduced by the patient placement of the device. We characterize these errors and
present a software solution to correct the effect of the errors on the iVCG signals.
We also describe the design of machine learning methods to improve automatic diagnosis and
prediction of various heart conditions. Methods very similar to the ones described in this dissertation can
be used on the long term, full diagnostic quality ‘Big Data’ such that the iVCG will be able to provide
further insights into the health of patients.
The iVCG system is potentially breakthrough and disruptive technology allowing long term and
continuous remote monitoring of patient’s electrical heart activity. The implications are profound and
include 1) providing a less expensive device compared to the 12-lead ECG system (the “gold standard”);
2) providing continuous, remote tele-monitoring of patients; 3) the replacement of current Holter shortterm monitoring system; 4) Improved and economic ICU cardiac monitoring; 5) The ability for patients to
be sent home earlier from a hospital since physicians will have continuous remote monitoring of the
patients.
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CHAPTER 1. INTRODUCTION

1.1 Contribution of Engineering in Cardiology
The continuous contraction and expansion of the heart that is responsible for blood circulation is
caused by an electric signal emanating from the brain. Consequently, a time varying electric field is
produced around the heart affecting all the organs around it. Physicians, with the assistance of engineers
and scientists, have sought to measure this electric field, first with the hope of mapping the changes in
electric field to cardiac anomalies and second, to better understand the anatomy and physiology of the
heart. [1]
In the 19th century electrodes were placed on the human chest to measure the electric current
caused in the tissue produced by the electric field. The first ever electrocardiogram or ECG is attributed to
A.D. Waller. In 1887, he placed electrodes on the front and back of a patient’s chest and measured the
electrocardiogram on a Lippmann's capillary electrometer [2]. Figure 1.1 shows an excerpt of the ECG
measured in time by Waller. [3]

t
Figure 1.1 The first human electrocardiogram published by Waller in 1887 [3]
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1.1.1 Electrocardiography
The electrocardiogram (ECG) is an electrical representation of the contraction and expansion of
the heart as read by electrodes placed at strategic points on the body. An ECG device records the heart’s
electrical activity and indicates whether the rhythm of the heartbeat is steady or irregular [4]. The 12-lead
ECG that is used today, which is the gold standard for cardiac monitoring, reflects the many engineering
efforts directed towards cardiology, in terms of designing hardware for sufficient amplification and
removal of 60 Hz noise in weak, distorted electric signals from the body, and in developing efficient
signal processing to remove other noise elements in the signals such as baseline wander and muscle
artifact. Figure 1.2 shows a typical 12-lead ECG and electrode connections.

Figure 1.2 Twelve-lead ECG: electrode positioning
The ECG provides a representation of the rhythm of the heart and thereby provides important
markers for physicians to diagnose cardiac diseases and thus is referred to as a full-diagnostic quality
device. The information available through the ECG enables a trained physician to diagnose conditions
such as, atrial fibrillation, atrial flutter, ventricular fibrillation, myocardial infarction, hypertrophy, acute
coronary syndrome among many other conditions (including sleep apnea) , varying in seriousness from
negligible to potentially fatal. [1]

2

1.1.2 Vectorcardiography

Figure 1.3 The view of the heart vector in three Cartesian planes [3].
In order to better understand the rather complex electrical activity of the heart, it can be modeled
as a single fixed dipole having a time varying electric force vector, with a magnitude and a direction. This
is called heart vector. The model serves as a good approximation of the electrophysiology of the heart
with little loss of generality. The measuring of the X, Y and Z components of this vector can then allow
us to capture the electrical heart of the heart comprehensively. [1]
Figure 1.2 shows the 3-dimensional, time-varying heart vector projected onto the three Cartesian
planes: Transverse, Sagittal and Frontal. The method of measuring this vector is called
Vectorcardiography and will be described in detail in Chapter 2.
1.1.3 Implantable Cardiac Rhythm Management Devices
Another area where engineering research and application greatly benefits the treatment of cardiac
disease is cardiac rhythm management (CRM), and is reflected in devices such as the implantable
pacemaker, Implantable Cardioverter/Defibrillator (ICD) and Cardiac Resynchronization Therapy (CRT)
device.

3

The heart is stimulated by a natural “pacemaker” that applies electrical signals to the heart and
causes the muscles of the heart to contract. These electrical signals set the rhythm of the heartbeat. In
certain situations, the natural pacemaker or the subsequent conduction path in the heart does not function
properly resulting in improper heart rhythm or ‘arrhythmia.’ Implanted CRM devices are used to monitor
and correct arhythmia. The respective functions of these devices, which include sensing and actuating,
vary depending on the type of arrythmia. These devices are implanted in the patient’s chest area close to
the collarbone. Appropriate voltage (actuation) is administered to the heart based on the necessity. Often
times these devices apply a large shock to the heart in order to treat a potentially fatal arrhythmia and
bring the patient’s heart back into normal function.
The usefulness of the impantable devices is demonstrated by the high survival rate among
patients who get immediate (less than 3 minutes) treatment when they suffer potentially fatal heart events
called Sudden Cardiac Death (SCD) events. Conversely, There is a low survival rate among patients who
do not get immediate treatment. [5]
These devices have stringent requirements of power, durability and reliability. They have to
continuously monitor the heart of the patient with high accuracy. Since they are implanted in the body,
they have to function for long periods of time without needing replacement. This time period is usually 810 years. [6]
1.2 Research Motivation
Heart disease is the leading cause of death globally. The number of deaths that occur worldwide
each year, because of cardiac related events is nearly 17.3 million and it is estimated that the number will
reach 23 million by 2030. One of the main causes is Myocardial Infarction (MI), commonly known as a
‘heart attack.’ Apart from this dangerous cardiac abnormality, there are multiple cardiac events that lead
to the suffering and death of many [7]. Moreover, according to [5], “Nearly 400,000 people experience
potentially lethal cardiac arrhythmias (irregular heart action caused either by physiological or pathological
disturbances) in the United States each year.”
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In [8], it is shown that people can be saved with 67% probability, if detection and consequent
action is taken immediately after suffering from a Sudden Cardiac Death (SCD) event. Moreover,
conditions such as paroxysmal atrial fibrillation, if predicted, can be avoided altogether with appropriate
and timely pacing treatments. [9]
From the above, a case can be made, (and is made in the literature [10]), that continuous, long
term monitoring is essential not only to monitor and manage high-risk patients but also to avert and
forewarn of cardiac events in non-patients as well.
Towards this end, there are many devices in the market that are able to monitor patient cardiac
activity. These devices are called ambulatory ECG devices. The Holter monitor is an example of such a
device [11]. However, these devices are unable to provide comprehensive, full diagnostic-quality
monitoring like the 12-lead ECG. As mentioned before, the 12-lead ECG is referred to as the gold
standard and has 4 probes that are placed on the body extremities and 6 precordial electrodes on the chest
(near the heart). From these 10 electrodes, 12 signals or ‘leads’ are measured. Some leads are derived by
linear combination of other leads to make a total of 12. The 12-lead ECG is able to diagnose the full range
of cardiac anomalies that are capable with an ECG device. Hence the term ‘full diagnostic quality
monitoring’ is ascribed to it. State-of-the-art ambulatory ECG devices do not have the same superior level
of monitoring and hence are not ‘comprehensive’ in monitoring patients. Due to its bulky form and
obtrusiveness to patients, the 12-lead ECG cannot be used effectively for ambulatory monitoring. [4]
In this dissertation, methods are presented that enable the design of a comprehensive (full
diagnostic quality), long term and continuous heart monitor that is unobtrusive to the patient. This device
is dubbed the Integrated Vectorcardiogram (iVCG). Figure 1.4 shows a typical iVCG system and shows
that the device may be connected to a smart phone, hospital server and/or a pacemaker as well.
Additionally, novel methods are presented that leverage long-term (“big”) data recorded by an
iVCG to diagnosis heart conditions and ultimately predict heart conditions, with the overarching goal of
improving patient outcomes.
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Pacemaker

Figure 1.4 The iVCG system
1.3 Contributions and Organization of this Dissertation
The dissertation is organized as follows: in Chapter 2, a literature survey is presented about the
background of this dissertation, which is the foundation of the presented research. The electrical activity
of the heart and the models used to understand it, such as the single-dipole model is described. Its
usefulness in diagnosis is discussed. The measurement devices of cardiac electrical activity are described,
namely the electrocardiogram (ECG) and the vectorcardiogram (VCG). The engineering methods and
techniques used in this research are reviewed in a detailed manner followed by a survey of machine
learning methods used in cardiac applications. Finally, a description of the Physiobank database, which
has been used multiple times in this research, is presented.
In Chapter 3, approaches for the diagnosis of heart conditions using machine learning approaches
are presented. In Chapter 4, the Integrated Vectorcardiogram (iVCG) is introduced. The device is able to
record and transmit 12-lead ECG equivalent information, where the 12-lead ECG is the gold standard for
heart monitoring. Chapters 5 and 6 present the underlying methods developed in this research that make
the working of the novel iVCG possible, namely the correction of device misplacement on the body and
conversion to 12-lead ECG.

6

Chapter 7 discusses the impact of predictive analytics using machine learning applications for a
device such as the iVCG that continuously monitors and stores high dimensional data and some novel
approaches to predicting heart conditions are presented. In Chapter 8 a summary of the research presented
in this dissertation is given and future directions are discussed.
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CHAPTER 2. CARDIOLOGY BACKGROUND AND LITERATURE REVIEW

2.1 Electrophysiology of the Heart and the Single Dipole Model
This section describes the electrophysiology of the heart at the physical level and the introduction
of the single dipole model, which is a useful method that describes the complex electrophysiology of the
heart.
The continuous contraction and expansion of the heart that is responsible for blood circulation in
the body is caused by an electric excitation of the cardiac muscle tissue. There are five separate kinds of
heart tissue that aid in this function: the sinoatrial node (SA), the atrioventricular node (AV), the Purkinje
fibers and the bundle of His, and the atrial and ventricular muscle tissue. [1]
The electric impulse, which can be described as the motion of ions through the cardiac tissue, is
generated at the SA node and is radially propagated through the atrial muscles causing them to contract. It
then reaches the AV node, which acts as a ‘repeater’ and propagates the signal through the Purkinje fibers
and the bundle of His. The impulse then passes through the ventricular muscles causing them to contract
as well. A figure showing these sites in the heart is seen in the next section in Figure 2.2.
Cardiac muscle, specially atrial and ventricular muscle is made up of longitudinal, rod-shaped
cells called myocytes. These are the functional unit of the heart muscle. Each myocyte is surrounded by a
plasma membrane called the sarcolemmal. Although the sarcolemmal is itself an insulating material it
contains a network of channels called the ion channels that allow ions to pass through them.
As mentioned earlier, the electric impulse (also called action potential) is propagated in the form
of ions, specifically Ca2+ and Na+ ions. The sarcolemmal around each myocyte contains its own reserve of
ions and requires an influx of ions from neighboring cells to release them. This mass release of Ca2+ and
Na+ ions causes a physical contraction of the myocyte. Subsequently, the impulse is said to propagate to
the neighboring cells and the process continues causing a global contraction of the heart muscle. After
8

contraction, the muscle cells expand and the ion reserves are refilled in preparation for the next
contraction. This process is called repolarization. This process, which constitutes one heart beat is called a
‘repolarization cycle.’
The electric behavior of the each myocyte is quite complex, as is its relationship with the
collective electric activity of the whole heart. In order to sufficiently understand this relationship a
mathematical model is needed. Physicians and scientists have agreed that the ‘single dipole model’ is a
sufficiently accurate way to describe the electrical activity of the heart. [1]

Figure 2.1 The view of the heart vector in three Cartesian planes [4].
The single dipole model assumes that the activity of the heart at any instant of time can be
approximated as a single fixed dipole. This results in an electric field, which causes a current in the
neighboring body tissue. This current is read on the surface of the skin with electrodes. The orientation
and magnitude of this dipole is called the heart vector and changes during the course of the repolarization
cycle. This causes the time-varying signal on the skin surface that can be observed on the
electrocardiogram (ECG).

9

Figure 1.1 shows the orientation and magnitude of the heart vector for different time instances
during one repolarization cycle in the sagittal, frontal and transverse planes.
2.2 Twelve-Lead ECG
Figure 2.2 shows the typical surface electrocardiogram (ECG) and maps different stages in the
ECG to their corresponding events in the heart. The cardiac impulse travels from the SA node to the atria,
giving rise to the P wave. After atrial contraction, the impulse travels to the AV node which corresponds
to the PR interval. Subsequently, the signal propagates through the Purkinje fibers and the bundle of His,
causing ventricular contraction. This is seen in the QRS complex. The ST segment marks the period
showing the continuing effect of the action potential in the ventricles. Finally the T wave indicates the
repolarization of the ventricles.

Figure 2.2 The human heart showing the important sites of the conduction system. The overlay shows a
picture of a typical ECG and arrows are drawn from various stages on the ECG to the corresponding site
of activation in the heart.
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Due to the variety of electrical activity in the heart muscles and its rather large structure, more
than one ECG lead is required to accurately describe the electric activity of the heart and thereby its
health. The 12-lead ECG is the well-known solution to this problem.
Figure 2.3 shows the 12-lead ECG and the typical electrode placement. The familiar 12-lead ECG
is referred to as the ‘gold standard’ in the medical literature and industry. The 12-lead ECG consists of 12
signals or leads read from 10 electrodes placed at different positions on the human body. The 12 leads are
named I, II, III, aVR, aVL, aVF, V1, V2, V3, V4, V5, and V6. The 12-lead ECG is said to
comprehensively capture heart activity in all three dimensions. It is said to capture full diagnostic-quality
information. Due to its bulky form and numerous wires, it is not suitable for portable or ambulatory
cardiac monitoring. It is limited to in-office visits.

Figure 2.3 Twelve-lead ECG: electrode positioning
2.3 Vectorcardiography
As explained in the earlier sections, in order to better understand the rather complex electrical
activity of the heart, it can be modeled as a single fixed dipole having a time varying electric force vector,
with a magnitude and a direction. This is also called heart vector. The model serves as a good
approximation of the electrophysiology of the heart with little loss of generality.
11

It follows that measuring the X, Y and Z components of this heart vector in time provides a
comprehensive description of the electrical activity of the heart. [12]
The vectorcardiogram (VCG) is an invention that embodies this idea. This device uses a plurality
of strategically placed electrodes on the body that record the X, Y and Z components of the heart vector.
Of course these are time dependent since the heart vector itself is time dependent. The original idea for
the VCG was presented in the 1930s. Frank invented the first popularly accepted version of the VCG in
1956. It was called the Frank’s VCG [13]. Over the years, the popularity of the VCG diminished as the
12-lead ECG gained precedence and established itself as the ‘gold standard’ of cardiac monitoring even
though the quantity of information in the VCG is at least equivalent to that of the 12-lead ECG and some
suggest that the VCG may contain more information that is useful in certain circumstances. In recent
years thanks to the improvement in computational capacity, interest in the VCG has resurfaced and may
be a viable option for ambulatory cardiac monitoring applications. [14]

Figure 2.4 Frank’s VCG: electrode positioning [15]
Figure 2.4 shows the Frank’s VCG. The figure shows the electrode placement and the position
where the X, Y and Z electrodes are recorded. The notation FP, HP and SP stand for: frontal plane,
12

horizontal (or transverse) plane and sagittal plane. The letters, H, M, I, E C and F denote the electrode
positions. The leads 1 X, Y and Z are calculated by using combinations of these electrodes. In this
dissertation, we will consider an integrated VCG (the iVCG) that is compact in design and allows the
continuous collection of diagnostic-quality “big data” to both analyze and predict cardiac events.
2.4 Machine Learning for Cardiac Applications
Machine Learning [16] is a branch of artificial intelligence that enables a computer or an
embedded system to detect patterns in data without being programmed, a priori, with explicit rules. The
learning system develops rules based on labelled data provided in a training mode. It can effectively aid
or replace expert (i.e., physician) involvement in many situations. [17] [18], [19]–[23],[24]
Typically, the data are divided into three phases: (1) training data, (2) validation data and (3)
testing data. The training data are used to teach the system to develop rules. Each outcome is labeled
(including “normal”) and the system knows this label. The validation data are then used to perform
preliminary testing on the algorithm. The testing data are used to perform a final test on the accuracy of
the algorithm [16]. The testing and validation data is not labeled.
The rest of this section records a survey of some work done where machine learning techniques
are used to diagnose heart conditions.
In [25]–[28] a few high level classifiers are described, which have been used in ECG
classification problems such as diagnosis of myocardial infarction (MI), commonly known as a heart
attack. First the authors use a transformation method on the ECG data (e.g. Discrete Wavelet Transform,
Fourier analysis) or use a certain feature of the ECG data (e.g., ST-segment slope, heart-rate). The authors
employ a classification algorithm such as: artificial neural networks [29] [30]–[32], support vector
machines [33]–[36] or hybrid expert systems [37]–[39] and show the results in the form of classification
accuracy. Accuracy typically ranges from 85% to 99%.
In [28] a survey of machine learning applications performed using mostly the MIT-BIH
arrhythmia database [40] (and occasionally the UCI database [41]), is presented. The paper describes
1

Each lead is typically a differential voltage of two electrodes.
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limiting factors such as: lack of standardization of ECG features, variability of ECG features due to stress
and activity, and individuality of the ECG patterns i.e., inter-class similarity and intra-class variability.
The research described in this dissertation shows good performance, indicated by a high
classification accuracy (>85%) in diagnosis. Today, there is increasing interest in machine learning in
diagnosis of cardiovascular diseases (CVD). This increasing interest coupled with the high-quality results
indicate the likelihood of a strong impact of machine learning on cardiac applications in the near future.
2.5 Review of Methods Used in Dissertation
2.5.1 Neural Networks
Neural networks (NN) or artificial neural networks were invented in 1943 by McCulloch and Pitts
[42]. They studied the neural structure of the brain in order to understand its logical functionality.

Figure 2.5 A typical feedforward neural network. The input vector is indicated by X and the output vector
is indicated by Y. The adaptable weights for each layer are indicated by the vector Wi.
Artificial neural networks are modeled after the neural network of the brain in order to learn
complex patterns or functionality [43]. A neural network consists of multiple nodes or ‘neurons.’ Each
neuron receives weighted inputs from multiple neurons and outputs a single value based upon a presumed
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gating function, for example, a sigmoid function. This output can further be fed into other neurons. Figure
2.5 shows a picture of a typical feedforward neural network. In Figure 2.5 the transposed input vector X'
= [x(1), x(2),….x(n)], where the index n indicates the time-domain sample number. Similar notation is
used for the transposed output vector Y'. The dimensions of the input, output, and weight vectors will
generally not be the same.
Information in the form of structured data is fed into the network through the input layer. Each
input is multiplied by an adaptable weight and fed into each neuron in the hidden layer. The network can
contain more than one hidden layer. Finally, the outputs of the final hidden layer are fed into the neurons
in the output layer.

Figure 2.6 Introduction page of the neural pattern recognition toolbox on Matlab [44].
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One typical application is called ‘supervised learning’ where a neural network is trained to detect
certain patterns that are consistent with a ‘label’ or ‘class.’ For example, a NN may be trained with
images of cats and dogs to find patterns that accurately differentiate between the two animals. In this
example the images of cats and dogs may be fed into the NN as a vector of pixel values. During training,
each image has a label either ‘cat’ or ‘dog’ which is represented at the output neuron as ‘1’ and ‘0.’ The
weights are then trained over multiple images of cats and dog each with their appropriate label. During
this phase the NN should learn what patterns in the images constitute a ‘1’ (cat) or ‘0’ (dog). In other
words, the NN must be able to, with high probability, adjust all the weights in such a way that will make
the output neuron fire ‘1’ when a picture of a cat is presented or ‘0’ when a picture of a dog is presented.
2.5.2 Neural Pattern Recognition Toolbox in Matlab
The neural pattern recognition toolbox in Matlab [44] was used for the machine diagnosis and
prediction described in this dissertation. The toolbox allows you to define the neural network in terms of
number of hidden neurons in a two layer feedforward network. The input data and labels can be specified
in the Matlab workspace. Training and testing split is user specified. The toolbox allows the user to easily
train the neural network and a list of useful metrics are displayed including, ROC curves, confusion
matrices, cost function vs training epochs etc. Figure 2.6 shows the introduction page of Matlab’s neural
pattern recognition toolbox.
2.5.3 Least-Squares Optimization
The least-squares (LS) method is a statistical tool used for analytically approximating an
unknown linear relationship between two or more observed variables [45]. For example, if there is an
unknown relationship between observed variables e (dependent variable) and x, y, and z (independent
variables), we may use the least square method to realize a reliable model, e’ that approximates this
relationship. This model is generally a linear function of the observed independent variables
en ' = axn +byn +czn ,

(2-1)

where, n denotes the sample index. The solution for a, b, and c minimizes an objective function such as
the sum of squared errors (E). This is given by,
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2

E = ∑Nn=1 (en -en ' )

(2-2)

where the sample size is denoted by N. To obtain the solution for the a, b and c coefficients for the
minimum sum of squared errors, we solved (2-3) given below.
Ʃx2n
�Ʃyn xn
Ʃzn xn

Ʃyn xn
Ʃy2n

Ʃyn zn

Ʃzn xn

Ʃxn en
a
Ʃyn zn � �b� = �Ʃyn en �
c
Ʃzn en
Ʃz2n

(2-3)

Equation (2-3) is derived by differentiating (2-2) with respect to a, b and c respectively and equating the
result to zero. The solution of (2-3) gives the optimal values of a, b, and c.
2.6 Summary
This chapter introduced the physical and mathematical background for the research presented in
this dissertation. The electrophysiology of the heart and the single dipole model are explained along with
the 12-lead ECG and the VCG, which are leveraged and improved upon in this dissertation. A high level
survey of machine learning in cardiology is presented. This is followed by a review of methods used in
this dissertation, which include neural networks and the least-squares method.
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CHAPTER 3. MACHINE LEARNING METHODS FOR IVCG DIAGNOSIS

3.1 Introduction
Diagnosis is an essential feature in the iVCG device (and also other low power wireless
ambulatory ECGs). Making use of the Big Data of patients recorded with the iVCG it is possible to
design diagnosis algorithms for a plethora of conditions using machine learning. Moreover, patient
specific diagnosis can be achieved, which can also benefit from other sensory sources. In patient specific
diagnosis, each individual patient’s medical history and other physiological markers are taken into
consideration when performing diagnosis in order to provide more targeted, individualized and effective
treatment [46], [47]. To this end there is an opportunity for a flexible machine-learning framework that
can incorporate other sensory sources and also be easy to implement in a low-power environment i.e., it
should be computationally inexpensive. Such a framework is described in this chapter along with some
results using the Physiobank database [40]. This work has been published in [48].
In section 3.2, we present a literature review of the technologies that can benefit from this
research. In section 3.3 we describe the heart conditions that are diagnosed using machine- learning
methods used in this dissertation. Section 3.4 describes the database used for our research. Section 3.5 and
3.6 presents the simulation setup and results. Finally, we present our conclusions in section 3.7.
3.2 Wireless ECG Devices
As discussed in chapter 2, the electrocardiogram (ECG/EKG) is an electrical representation of the
polarization cycle of the heart as read by electrodes placed at strategic points on the skin surface.
Conventionally, 10 electrodes are used to display the ECG and the combined output is known as
the 12-lead ECG because 12 distinct signals are recorded and displayed by linearly combining the signals
from the 10 electrodes. These signals provide a 3 dimensional (spatial) view of the heart’s electrical
activity to the physician. With the advancement in technology, a smaller version of the 12-lead ECG that
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uses 1 - 3 leads has been realized, that can be attached to the human body, and can continuously monitor
the heart’s electrical activity. This type of ECGs is called an ambulatory ECG, or on-body wireless ECG,
and provides only a one or two- dimensional view of the heart’s electrical activity. Note that the
information that can be provided to the physician by the 12-lead ECG is much more comprehensive than
that of the wireless ECG. As compared to the 12-lead ECG, which provides a three-dimensional view of
the heart’s polarization cycle, only a one or two-dimensional view is provided by the wireless. It is
recognized by the medical community that the amount of information increases as the number of
(independent) dimensions is increased from one to three [4]. However, the 12-lead ECG is not portable
and cannot be used for continuous monitoring without hindering the patient’s daily activities.
Devices like the one shown in Fig. 3.1 are used to run with a low power budget and can monitor
the heart for long periods of time. They are also capable of wirelessly communicating the patient’s ECG
with a smart phone. However, this level of monitoring is not diagnostic quality.
3.3 Heart Conditions: Atrial Fibrillation and Atrial Flutter
3.3.1 Atrial Fibrillation

Figure 3.1 Representative wireless ECG device (marketed by IMEC) [48]
Atrial Fibrillation is a serious condition that affects the atrial chambers of the heart. An erratic
sinus rhythm presents itself in the atria along with a disorganized rhythm that is easily observed in the
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ECG. The rhythm is marked by increased heart rate (i.e., decreased RR interval). Further, The RR interval
does not stay constant with time and usually varies with no perceivable pattern. Hence, an RR interval
variation graph called ‘Tachogram’ is often used to diagnose Atrial Fibrillation [49]. An absence of the P
wave may also be observed. Figure 3.2 shows a 10 second excerpt of a patient’s ECG showing signs of
Atrial Fibrillation.

Figure 3.2 A 10 second excerpt of a patient’s ECG showing Atrial Fibrillation
3.3.2 Atrial Flutter
Atrial Flutter is another type of atrial arrhythmia that affects the atria and is characterized by a
fast heart rate with morphological differences in the P wave of the ECG. Patients may experience chest
pain, shortness of breath and dizziness due to this condition. The ECG can be characterized with a
symmetric P wave or a saw tooth shaped P wave. Additionally, multiple peaks can also accompany it,
where there is no flat line between RR peaks as is typically seen in normal ECGs. There are similarities
between the symptoms of Atrial Flutter and Atrial Fibrillation and hence it is essential that a clear
diagnosis is made between the two [50]. Figure 3.3 shows a 10 second excerpt of a patient’s ECG
showing signs of Atrial Flutter.
3.4 Intracardiac Atrial Fibrillation Database (IAFDB)
We used a database from Physiobank that contained surface ECGs [40]. The ECG information
was recorded while the patient underwent an episode of either Atrial Fibrillation [AFB] or Atrial Flutter
[AFL]. The data were digitized at 1 KHz and contained 8 signal traces for every patient. Another database
containing surface ECGs of patients with a normal heart beat or Normal Sinus Rhythm [NSR], also from
Physiobank [40], was adapted into our experiment in order to teach the learning algorithm to differentiate
between normal and abnormal heart patterns.
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Figure 3.3 A 10 second excerpt of a patient’s ECG showing anomalies that indicate Atrial Flutter [50]
3.5 Neural Network Setup
The ECG data is a set of voltage fluctuations in time that form patterns depending upon the
condition of the heart. For example, in the case of atrial fibrillation the ECG could show a rate of over
300 peaks per minute (normal rhythm follows a pattern of 72 peaks per minute). The algorithm that we
employ must be trained to recognize patterns and associate them with specific arrhythmias.
To achieve this goal we use a learning system technique called an Artificial Neural Network
(ANN) [43]. Artificial Neural Networks are based on the concept of biologically occurring neural
networks that are present in the central nervous system and are responsible for human learning and
computation. An ANN uses a plurality of nodes or ‘neurons’ [the circles in Fig. 3.4] to recursively train
and adapt weights [the W’s in Fig. 3.4] to correctly recognize patterns and associated labels (classes). The
labels in our experiments are 1) Atrial Fibrillation, 2) Atrial Flutter, and 3) Normal Sinus Rhythm. ANN
systems are especially useful in recognizing patterns and are used frequently in ECG analysis [3], [6]–[9].
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Figure 3.4 Architechture of a feed-forward neural network for our experiment
3.6 Results
We present our results from passing the surface ECG signal through an ANN algorithm using the
MATLAB neural network toolbox. [44] [15]

Figure 3.5 Confusion matrix generated by the MATLAB toolbox.
The surface ECG signals are divided into data segments of a constant time period. This time
period was chosen to represent a standard PQRST signal of a normal heartbeat [10]. This amounted to
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about 106 samples after appropriate down sampling. These data segments were labeled according to the
heart condition (Atrial Fibrillation, Atrial Flutter or Normal Sinus Rhythm) and input to the neural
network. The neural network had 3 layers, input layer, output layer and one hidden layer containing 10
neurons. A standard back propagation algorithm [51] was used to train the weights. The data is split so
that 70% was used for training, 15% for validation and 15% for testing. A recurrent neural network,
which leverages sequential dependence in the inputs, may also be used for ECG diagnosis especially
when the ECG traces show a condition that evolves with time.
Figure 3.5 shows the confusion matrices for training, testing and validation. The rows of each
matrix indicate the true classes and the columns indicate the class that was predicted by the algorithm. We
can see that 99.2 percent of data segments were correctly classified. Figure 3.6 shows the number of
iterations on the data set (called epoch) and its relationship with the mean squared error for training,
validation and testing.

Figure 3.6 Relationship between epochs and mean square error in training, validation and test data
3.7 Concluding Remarks
A high degree of accuracy was achieved in predicting atrial arrhythmia in 8 patients using only an
external ECG when we used an ANN neural network with 10 hidden neurons with a back propagation
algorithm. The use of neural networks presents us with two distinct advantages. First, the neural network
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offers a framework that is conducive to incorporating different sensory sources and thereby enables data
fusion (process of integrating multiple sensory sources into decision making or diagnosis), to help
improve the diagnosis [52]. For example, the neural network can be retrained while including input from
an intracardiac electrogram (EGM) of an implantable pacemaker or input from a glucometer. Second,
even though training the model on a neural network may be computationally heavy, the deployment of the
model is very simple. That is, the decision making based on the machine learning algorithm is made while
consuming little power. This is useful for low power devices.
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CHAPTER 4. INTEGRATED VECTORCARDIOGRAM (IVCG)

4.1 Introduction
This chapter presents the proof-of-concept investigation for a miniaturized, diagnostic-quality
integrated vectorcardiogram (iVCG) system for ambulatory on-body applications that continuously
monitors the electrical activity of the heart in three dimensions [15]. We investigate the minimum
distance between a pair of leads in the X, Y and Z axes, such that the signals are distinguishable from the
noise and remains at diagnostic quality. The target dimensions for our VCG are 3x3x2 cm, and based on
our results, it is possible to achieve these dimensions. The next chapters describe the realization of the
iVCG system that includes processing, learning and communication capabilities. This work has been
published in [15].
Cardiac Rhythm Management (CRM) is the field of cardiovascular disease therapy that relates to
the detection and treatment of abnormally fast and abnormally slow heart rhythms [1]. Current rhythm
management systems manage heart activity by monitoring electric impulses generated by the heart, or via
other means such as blood acceleration as it leaves the heart, and take corrective action upon sensing
dangerous or potentially dangerous changes in normal heart activity. Cardiac rhythm management devices
have come a long way from when they were first invented and used in the 1950’s. Most such systems
now have external controllability and monitoring so that the physician can check the condition of the
heart through an external device, on a routine basis, typically on a monthly basis. PDAs and cell phones
are used to facilitate this function. Implantable defibrillator devices (ICD) have a built-in
Electrocardiogram [EGM] monitor, called an intracardiac electrogram (EGM) monitor. [53]
Vectorcardiography [VCG] presents a compact three-dimensional (3D) view of the depolarization
(depolarization cycle) of the heart by calculating the magnitude and direction of the electrical signals
emanated from the heart [1], [4]. These vectors are used to make 3 projections of the polarization event of
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the heart, namely Coronal (frontal), Transverse (horizontal) and Sagittal (vertical) plane.
Vectorcardiography is presently used mostly for didactic purposes to teach students of biomedical
sciences, physiological aspects of electrocardiography. In these cases, the 12-lead ECG is converted into a
vector with X, Y, and Z components via a 12x3 matrix transformation. The VCG and the 12-lead ECG
represent the same information, albeit in different formats.
The principal advantage of the VCG is that it provides the same information as the 12-lead ECG
but with fewer leads. This is achieved, as mentioned, by manipulating these orthogonal vector signals to
yield a conventional ECG signal.
The VCG was created in the 1930’s and was viewed primarily as a teaching tool [13]. In this
chapter, we describe how the VCG concept can be extended to enable real-time monitoring of the heart’s
electrical activity of patient with a small form factor device that can be worn on the body of the patient. In
section 4.2, we present a literature review of the vectorcardiogram. In section 4.3 we describe our novel
VCG, dubbed Integrated Vectorcardiogram (iVCG) as a part of a CRM system. Section 4.4 presents the
test setup and results of our approach. Finally, we present our conclusions in section 4.5.
4.2 Literature Review

Figure 4.1 The view of VCG in three Cartesian planes [4]
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Vectorcardiography (VCG) is a method of using a series of vectors to record the magnitude and
direction of the electrical forces in electrical cardiac activities. Figure 4.1 shows a view of the VCG signal
from three Cartesian planes (X-Y, Y-Z and X-Z). VCG and electrocardiogram (ECG) are both reflections
of the electric cardiac activities and they differ in the recording methods. It is widely accepted that VCG
is an important complement and improvement to ECG and a more accurate clinical diagnosis may be
obtained when combining them together [13]. The amount of information in the VCG is at least as much
as the 12-lead ECG and may contain information that is useful in certain circumstances. The VCG was
not commonly applied in clinical diagnosis before because of the higher cost of the equipment. However,
along with the improvement of VCG instruments and simplification of the recording method, we expect
that VCG-based systems will be more widely used in clinical research and applications. [15]
The initial concept of VCG was introduced in 1920 [54]. The author manually graphed a series of
vectors to represent the electric forces of depolarization and repolarization according to the recordings of
the electric cardiac activity. The first technique for recording the VCG was reported in 1936 and 1937 in
[55]. The Frank system [56] was an improved system for spatial vectorcardiography which made the
VCG clinically practical. It was introduced in 1956 and is still widely used at present.[62]
Some recent research shows the benefits of using the VCG in different aspects in clinical
medicine field. In [57], a new and simple method is presented, which is based on the baseline VCG
analysis to predict responses in cardiac resynchronization therapy (CRT) and in [58] the authors reported
that the frontal plane heart depolarization vector cardiogram (HDVC) can be diagnostically applied to
identify certain cardiac disorders. The authors in [59] use a method that combines several VCG variables
to obtain better diagnostic accuracy of left ventricular hypertrophy (LVH), compared to the conventional
ECG criteria. Furthermore, there is also considerable recent research focused on the representations or
computations of VCG signals. For example, a Bayesian method which can determine a VCG, tailored to
each specific patient, is proposed in [60]. In [61], the authors derive the 12-lead ECG and 3-lead VCG
from 3 measured leads with 5 electrodes, which is an efficient way to obtain the ECG and VCG and has
significance in acute patient care. Some research is presented in [62] regarding the statistical affine
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transformations between 3-lead VCG and 12-lead ECG, which is proved to be more accurate than the
traditional methods such as Dower’s transformation. In [63], different methods are compared in
computing spatial QRS-T angles (SA) in VCG signals and it is discovered that the method which uses the
Kors matrix shows superior correspondence than the others. The authors in [64] propose a modeling
approach based on multi-scale adaptive basis function to characterize both temporal and spatial behaviors
of VCG signals. Their proposed model shows great potential to model space-time cardiac pathological
behaviors and also has some benefits in practical applications. In [65], the authors present an investigation
on spatiotemporal VCG signal representation, which can be used to get a better medical interpretation and
clinical applications of VCG. Their research presents both spatial and temporal characteristics of VCG
signals in dynamic representation, which benefits the assessment of cardiovascular diseases.
4.3 Integrated Vectorcardiogram (iVCG) System
In this chapter we present a novel on-body vectorcardiogram, with a small form factor, that is part
of a cardiac rhythm monitoring system (CRM) shown in Fig 1.3 in chapter 1. It is dubbed the integrated
vectorcardiogram (iVCG). The iVCG has a very small form factor, such that it can be a long-term
monitoring ambulatory device that can continuously monitor the electrical activity of the heart in three
dimensions for a while being unobtrusive to the patient. Importantly, the iVCG device is able to record
information equivalent to that of the 12-lead ECG and is thus of diagnostic quality. The main challenge is
to build a small device (small separation between leads) to capture the activity of the heart in X, Y and Z
dimensions. That is, the VCG uses three orthogonal systems of leads to obtain the 3D electrical
representation of the heart. This device may be enabled with learning and wireless communication
capabilities that will be described in the following chapters. The iVCG device can be connected to a smart
phone, pacemaker (CRT/ICD), and an associated server, as shown in Fig. 1.3 in chapter 1. Together, this
is referred to as the iVCG system.
The first step to realize our iVCG system is to design and build a miniaturized VCG that can be
worn on the body. To achieve this, we placed two pairs of electrodes on the body (one pair in the X-axis
and another pair in the Y-axis at different distances) as illustrated in Fig. 4.2. For the Z-axis, we place one
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electrode on the chest and the other electrode on the back. As the proximity between the leads in the X
and Y axes is decreased, the amplitude and wave shape of the signals will, at some point, suffer loss of
amplitude and become distorted (orthogonality) and be degraded relative to that of a 12-lead ECG.

Figure 4.2 Location of the electrodes on the body in the X and Y axes and recording system.
We built the breadboard version of the VCG to make measurements and experiment with signal
processing, as shown in Fig. 4.3., before we construct the miniaturized VCG. The goal of the miniaturized
VCG design is to fit all the electronics into a 3x3x2 cm package. The breadboard (Signal Measurement
Circuit in Fig. 4.2) is a 4-layer PCB used to connect the electrodes and collect the electrical signals
coming from the heart. The dimensions are 9.65x6.35 cm. The breadboard contains one differential
amplifier for each dimension (X, Y and Z). Those signals are passed to the computer through a data
acquisition card (Digital Data Converter in Fig. 4.2) for post processing.

Figure 4.3 Miniaturized VCG “breadboard” recording system.
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From preliminary results, we saw that 60 Hz noise is introduced in the measurements due to the
electrical power system. Because of this, the Post Reception Signal Processing in Fig. 4.3 is used to
eliminate this unwanted 60 Hz noise signal. Additionally, the signal processing is used to reorthogonalize the measured data, and resolve any other issues that have arisen. In order to convert the
iVCG to a 12-lead ECG, a 12-lead ECG can be fitted for calibration at the time of fitting the iVCG device
to the patient. Both the iVCG and the 12-lead ECG are fed into an algorithm that determines the
underlying transfer function between the iVCG and the 12-lead ECG.

Figure 4.4 Measured signals for different distances in the X axis.
This transfer function will differ from person to person and must be ‘customized’ for each patient.
As a result, the VCG will be part of the ‘Personalized Medicine’ [47] revolution in medicine. The
following section presents results from our novel vectorcardiogram system.
4.4 Results
We ran tests to measure the electrical activity of the heart for different distances, and obtained
data for different distances between two leads in the X and Y axes, as shown in Fig. 4.4 and Fig 4.5.,
respectively. This information is useful to determine the minimum distance between two leads such that a
satisfactory diagnosis can be done. As was mentioned in the previous section, we placed an electrode on
the chest (Z–) and other one in the back (Z+) for the Z axis.
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Figure 4.5 Measured signals for different distances in the Y axis
As we can see in Fig. 4.4 and Fig 4.5., the closer the distance between the leads, the smaller the
amplitude of the signal and larger the noise. Figure 4.6 presents the measured and filtered signal for the
X-axis at a distance between the pair of electrodes equal to 10.67 cm. The post processing noise removal
algorithm using cascaded notch filters helps to remove the 60 Hz noise and other unwanted signals.

Figure 4.6 Measured and filtered signal in the X axis.
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The filtered signals for the X, Y and Z axes are shown in Fig. 4.7. The amplitude of the signal in
the Z-axis is larger than the X and Y-axes because the distance between leads is very large compared to
the distance in the X and Y-axis. These results, demonstrate that it is quite possible to miniaturize the
VCG for on-body ambulatory applications and achieve our targeted dimensions (3x3x2 cm).
With better signal processing and hardware tuning we were able get a signal with good fidelity at
distances of 1.7 cm in the X axis and 1.9 in the Y axis. This is shown in Fig. 4.8

Figure 4.7 Filtered signals for the smaller distances in the X and Y axis
4.5 Conclusions
The iVCG system could be a breakthrough and disruptive technology allowing long term and
continuous remote diagnostic-quality monitoring of a patient’s electrical heart activity. The implications
are potentially profound and include the following advantages: 1) provides a less expensive device
compared to the 12-lead ECG system (the “gold standard”); 2) continuous remote tele-monitoring of a
patient becomes possible; 3) the current Holter monitor system can be replaced; 4) ICU cardiac
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monitoring becomes much less complex and costly; 5) physicians may be able to send people/patients
home earlier because they have continuous remote monitoring of the patients.

Figure 4.8 Filtered X and Y signals for the smallest distances achieved after appropriate applification
In this chapter, we have presented proof of concept experimental results that strongly suggest that
our novel VCG can be realized. Moreover, in this chapter we describe the initial experiments focused on
collecting and processing the signals of the electrical activity of the heart. The machine learning
capabilities and other features of the iVCG will be discussed in following chapters.
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CHAPTER 5. IVCG: OPTIMIZATION FOR 12-LEAD TRANSFORMATION

5.1 Introduction
Cardiac Rhythm Monitoring (CRM) is the field of cardiovascular disease therapy that relates to
the detection of abnormally fast and slow heart rhythms. The vectorcardiogram (VCG), which was
invented in 1930s, is an example of a CRM device. In previous chapters, the VCG concept was shown to
be extendable to enable real-time, diagnostic-quality monitoring of the heart with the use of an integrated
VCG device (iVCG) with a small form factor that can be worn on the body for long periods of time. This
wireless VCG signal contains 3 orthogonal components that provide comprehensive, diagnostic-quality
cardiac information that is equivalent in information content to the 12-lead ECG, albeit in a different
format. At the receiver the VCG signals are transformed into a 12-lead ECG signal by a 12x3 matrix and
either analyzed or transmitted to the physician/hospital for further scrutiny. This is done so that current
medical personnel can perform a diagnosis using a familiar format.
In this chapter, we present a solution to the problem of transforming noisy and attenuated VCG
signals to the 12-lead ECG [66]. In section 5.2, we present a description of the problem of transformation
of the iVCG signals to the 12 lead ECG. In section 5.3, we present results using the least-squares (LS)
method to find the 12x3 transformation matrix that transforms the 3 component VCG to the 12-lead ECG.
Finally, in section 5.4, we present conclusions and future directions. This work has been published in
[66].
5.2 Transformation Matrix
The contraction and expansion of the heart is caused by an electrical excitation in the heart
muscle resulting in the formation of an electromotive field within the heart, dubbed the heart vector (HV).
An electric field is created in the rest of the body and the signal that is read from a point on the skin
surface, which is called lead, is the magnitude of this resultant electric field at that point on the body [63].
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The familiar 12-lead ECG is the ‘gold standard’ in the medical industry. The 12-lead ECG consists of 12
signals or leads read from 10 electrodes placed at different positions on the human body. The 12 leads are
named I, II, III, aVR, aVL, aVF, V1, V2, V3, V4, V5, and V6. As noted above, it is imperative that the
VCG information that is presented to the physician be in the form of the 12-lead ECG, since they are most
familiar with this format.
5.3 Least Squares Method
It has been shown that there is a linear transformation from the 3-component VCG signal to the
12-component ECG signal [1]. Cardiologists prefer to study the 12-lead ECG signal derived from the
VCG signal. The objective of this chapter is to demonstrate an effective means of determining the 12x3
matrix that characterizes this transformation for each person. In practice, the iVCG device will be fitted
on the patient along with a 12-lead ECG at configuration. Our approach is to use the VCG to derive an
ECG signal (called ê), and determine the matrix coefficients that minimize the difference (or errors)
between the derived ECG (ê) signals and the reference 12-lead ECG signals. As we show below, we use
the least squares fit to minimize the mean square error (MSE) and adaptively derive the optimum 12x3
transformation matrix.
We represent the coefficients to transform the VCG signal vector v to a 12-lead derived ECG
signal ê by the matrix relationship
𝑻𝑻𝑣𝑣 = 𝑒𝑒̂

(5-1)

where T is the 12x3 transformation matrix, v is the column vector of the x, y, and z components of the
VCG signal and ê is the 12-component derived ECG signal, which is also represented as a column vector.
𝒗𝒗′ = [𝑥𝑥, 𝑦𝑦, 𝑧𝑧]

𝒆𝒆′ = [𝑒𝑒1 , 𝑒𝑒2 , 𝑒𝑒3 , 𝑒𝑒4 , 𝑒𝑒5 , 𝑒𝑒6 , 𝑒𝑒7 , 𝑒𝑒8 , 𝑒𝑒9 , 𝑒𝑒10 , 𝑒𝑒11 , 𝑒𝑒12 ]

(5-2)
(5-3)

The ECG signal e can be represented as a column vector of 12 components or signals
representing the 12 leads (I, II,…,V6).
Note that we are suppressing the time dependency of the signals. The transposed matrix T can be
written as,
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𝑻𝑻′ = [𝒕𝒕′ 𝟏𝟏 , 𝒕𝒕′ 𝟐𝟐 , 𝒕𝒕′ 𝟑𝟑 , 𝒕𝒕′ 𝟒𝟒 , 𝒕𝒕′ 𝟓𝟓 , 𝒕𝒕′ 𝟔𝟔 , 𝒕𝒕′ 𝟕𝟕 , 𝒕𝒕′ 𝟖𝟖 , 𝒕𝒕′ 𝟗𝟗 , 𝒕𝒕′ 𝟏𝟏𝟏𝟏 , 𝒕𝒕′ 𝟏𝟏𝟏𝟏 , 𝒕𝒕′ 𝟏𝟏𝟏𝟏 ]

(5-4)

𝒕𝒕′ 𝑖𝑖 = [𝑎𝑎𝑖𝑖 , 𝑏𝑏𝑖𝑖 , 𝑐𝑐𝑖𝑖 ]

(5-5)

where ti’ denotes the transpose of the 3x1 coefficient vector for the ith ECG lead.

and where ai, bi and ci are the coefficients of the x, y and z components respectively. Note that the ith
component of ê can be written compactly as,
𝒆𝒆�𝚤𝚤 = 𝒕𝒕′ 𝑖𝑖 𝒗𝒗

𝑖𝑖 = 1,2, … ,12,

(5-6)

so that the ith lead of the derived ECG signal is given by the dot product of ti and v.
As noted earlier, we use the mean-square error [MSE] between the reference ECG signal vector e
and filter output ê to derive the optimal transformation matrix. Since the ith output êi only depends on the
ti vector, we can separately minimize the ith components of the MSE
𝐸𝐸�𝜀𝜀𝑖𝑖2 � = 𝐸𝐸[(𝑒𝑒�𝚤𝚤 − 𝑒𝑒𝑖𝑖 )2 ], 𝑖𝑖 = 1,2, … ,12

(5-7)

where ε is called the instantaneous error.
5.4 Results
5.4.1 Signal Acquisition

The ECG leads were simultaneously recorded along with the VCG signals on a volunteer using a
hardware acquisition board that was designed at the University of South Florida. The board was used to
capture multiple files of 45-second recordings.
The recordings were processed using Matlab to remove high frequency and 60 Hz power-line
noise. Each lead was segmented such that each segment represented one heartbeat. Each segment
contained 1391 samples.
By using the LS method detailed in chapter 2 section 2.5.3 we can show that the following
equation gives the solution to the coefficients for each lead of the ECG chosen separately.
Ʃ𝑥𝑥2𝑛𝑛

�Ʃ𝑦𝑦𝑛𝑛 𝑥𝑥𝑛𝑛
Ʃ𝑧𝑧𝑛𝑛 𝑥𝑥𝑛𝑛

Ʃ𝑦𝑦𝑛𝑛 𝑥𝑥𝑛𝑛
Ʃ𝑦𝑦2𝑛𝑛

Ʃ𝑦𝑦𝑛𝑛 𝑧𝑧𝑛𝑛

Ʃ𝑧𝑧𝑛𝑛 𝑥𝑥𝑛𝑛

Ʃ𝑥𝑥𝑛𝑛 𝑒𝑒′𝑛𝑛
𝑎𝑎
Ʃ𝑦𝑦𝑛𝑛 𝑧𝑧𝑛𝑛 � �𝑏𝑏� = �Ʃ𝑦𝑦𝑛𝑛 𝑒𝑒′𝑛𝑛 �
𝑐𝑐
Ʃ𝑧𝑧𝑛𝑛 𝑒𝑒′𝑛𝑛
Ʃ𝑧𝑧2
𝑛𝑛
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(5-8)

The sample index of the ECG and VCG recordings is denoted by n and ranges from 1 to 1391.
Since the equation gives the solution for an individual lead, the index i has been suppressed. Table 5.1
shows the transformation matrix after the method was applied to all leads.

Table 5.1 Transformation Matrix
a

b

c

I

-0.3

-1.17

0.008

II

-0.68

-0.857

-0.652

III

-0.98

0.32

-0.66

aVR

-0.02

1.605

0.318

aVL

0.646

-0.749

0.334

aVF

-0.833

-0.268

-0.656

V1

0.3

-1.17

0.009

V2

-0.57

0.15

0.51

V3

-0.52

-0.31

0.15

V4

-0.06

-0.89

0.042

V5

0.257

-1.255

-0.2

V6

0.001

0.013

1.174
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The following figures are representative of our results. Each of the three figures shows the
comparison between the measured ECG lead and the ECG lead derived from the above described method.
Figure 5.1 shows the derived and measured ECG for lead I. The green trace indicates the
measured lead and the blue trace indicates the derived lead.

Figure 5.1 Comparison of the reference and derived signals for lead I using the LS method.
Figure 5.2 shows the derived and measured ECG for lead aVF. The green trace indicates the
measured lead and the blue trace indicates the derived lead.

Figure 5.2 Comparison of the reference and derived signals for lead aVF using the LS method.
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Figure 5.3 shows the derived and measured ECG for lead V2. The green trace indicates the
measured lead and the blue trace indicates the derived lead.

Figure 5.3 Comparison of the reference and derived signals for lead V2 using the LS method.
The green and blue traces in the above figures, while not visually identical, are considered to be
diagnostically identical i.e., physicians confirm that there is no loss of diagnostic information when the
ECG signal is reconstructed (blue).
5.5 Concluding Remarks
The transformation matrix that determines the relationship between x, y and z leads of the iVCG
and the 12 lead ECG was accurately determined using the LS method. This capability, along with its other
features, may enable the iVCG to become a truly transformative wireless medical device enabling
continuous diagnostic-quality cardiac diagnosis.
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CHAPTER 6. IVCG: COMPENSATION FOR INADVERTENT ROTATION AND
DISPLACEMENT
6.1 Introduction
Electrocardiography (ECG or EKG) is the process of recording the electrical activity of the heart
over a period of time using electrodes placed on a patient's body. These electrodes detect the electrical
changes on the skin that arise from the heart muscle depolarizing during each heartbeat. To the trained
clinician, an ECG conveys a large amount of information about the structure of the heart and the function
of its electrical conduction system. Among other things, an ECG can be used to measure the rate and
rhythm of heartbeats, the size and position of the heart chambers, the presence of any damage to the
heart's muscle cells or conduction system, the effects of cardiac drugs, and the function of implanted
pacemakers [1]. The vectorcardiogram (VCG), which was invented in 1931, is an example of an ECG
device. As discussed in earlier chapters, this wireless iVCG signal contains 3 orthogonal components that
constitute the heart vector. The heart vector provides comprehensive, diagnostic-quality cardiac
information that is equivalent in information content to the 12-lead ECG, albeit in a different format [13].
At the receiver the VCG signals are transformed into a 12-lead ECG signal by a 12x3 matrix and either
analyzed or transmitted to the physician/hospital for further scrutiny.
In section 6.2 we present a detailed description of the effects of inadvertent iVCG rotation, which
we refer to as “the rotation problem” [67]. In section 6.3, we describe the ‘displacement problem.’ In 6.4
we present results that demonstrate that the original form of iVCG signal recorded from a disoriented
(i.e., rotated and displaced) device can be reproduced via software modeling and processing. This is
followed by the conclusion in section 6.5.
This research that is described here has been published in the IEEE Computer-Aided Modeling
Analysis and Design of Communication Links and Networks (CAMAD) conference [67].
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6.2 Rotation Problem
Although a physician or trained technician will initially install the iVCG in the appropriate
position, it is prone to subsequent errors introduced by the patient’s (re) positioning of the device. In this
chapter, we discuss the problem arising from inadvertent rotation of the iVCG device and its effect on the
iVCG signal. We demonstrate that it is possible to compensate for this effect and reproduce the original
signal using a purely algorithmic approach i.e., using only software processing.
Since there is no redundant information, in contrast to the significant redundancy in the ECG, the
iVCG device is more sensitive to position than the 12-lead ECG. Alternatively, it can be said that the
iVCG signal set is a sufficient statistic to comprehensively model the electrical activity of the heart [1],
[13], [68]. A precise position is necessary to ensure orthogonality and an accurate conversion to the 12lead ECG.
It is expected that either a physician or trained technician will initially install the iVCG device on
the patient to ensure precise positioning. The 12-lead ECG will also be attached at the time of installation
so the iVCG device can calculate the 12x3 coefficient matrix. The iVCG device is designed to monitor
the patient continuously round-the-clock, so the patient will likely remove it to charge it. When replaced,
the device will be prone to misplacement in the form of displacement and rotation from the preferred
original location and orientation.
The disorientation of the iVCG device will primarily occur in the Coronal (XY) plane causing a
shift in the projection of the heart vector in the coronal plane. Due to the curvature of the body the new X
and Y-axes will also undergo individual inclination that will cause a loss of orthogonality. The angle of
inclination depends on individual body type and cannot be estimated prior to installation of the iVCG
device on the patient.
6.3 Displacement Problem
The iVCG device will also be prone to position displacement due to errors in the iVCG device
placement on the part of the patient, perhaps due to changing the battery. Due to this displacement there
will be some distortion in the signal.
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The question that was answered in this research was: given the reference heart vector v is there a
method by which a signal from a displaced iVCG, vd can be restored?
The proposed method involves a least-squares (LS) technique similar to one used in the
transformation problem. Since a lead can be represented by linear combinations of other leads, we can
express the X and Y components of v as a linear combination of X and Y components of the vector vd.
[68]
𝑝𝑝1 𝑥𝑥𝑑𝑑 + 𝑝𝑝2 𝑦𝑦𝑑𝑑 = 𝑥𝑥

(6-1)

𝑞𝑞1 𝑥𝑥𝑑𝑑 + 𝑞𝑞2 𝑦𝑦𝑑𝑑 = 𝑦𝑦

(6-2)

Here, x, y are the X and Y components of v and xd and yd are the X and Y components of vd.
The coefficients p1, p2, q1 and q2 can be estimated using the LS method. In a real world scenario,
the processing unit will compare vd and v. Using the LS method it will compute the coefficients and use
them in the above equations and recover the normal signal.
6.4 Results
6.4.1 Minimum Mean Square Error (MMSE) Method for Rotation
In order to confirm that an algorithmic (software) correction of the iVCG signal from a
disoriented device is possible, we performed an experiment where the electrodes were rotated by a known
angle and the recorded signal was mathematically de-rotated using the rotation matrix. Specifically, the
iVCG signal was captured in normal orientation. This is called the reference vector and is denoted as v
containing X, Y and Z components. It was then rotated clockwise by 45 degrees and then in the anticlockwise direction. This vector is denoted as vr. The signal is de-rotated in software by multiplying the
vector, vr by the rotation matrix Rθ .
𝒗𝒗𝒔𝒔 = 𝑹𝑹𝜃𝜃 𝒗𝒗𝒓𝒓

(6-3)

where vs is the software de-rotated vector and the rotation matrix is
𝑐𝑐𝑐𝑐𝑐𝑐 𝜃𝜃
𝑹𝑹𝜃𝜃 = � 𝑠𝑠𝑠𝑠𝑠𝑠 𝜃𝜃
0
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− 𝑠𝑠𝑠𝑠𝑠𝑠 𝜃𝜃
𝑐𝑐𝑐𝑐𝑐𝑐 𝜃𝜃
0

0
0�
1

(6-4)

The angle θ indicates the angle of error rotation. It is + or – 45 degrees in the case of the above
described experiment.

Figure 6.1 Reference heart vector, v projected in XY plane with electrodes in normal position (blue),
vector vr from electrodes rotated in clockwise direction by 45 degrees (red,) and software de-rotated
vector vs (black).
Figures 6.1 shows the heart vector projected in the Coronal plane 1) when electrodes are in
normal position, 2) when electrodes are oriented by 45 degrees in the anticlockwise direction and 3) after
software de-rotation. Figure 6.2 shows a comparison of X and Y leads when recorded with normal
electrode placement vs. X and Y leads software-recovered from electrode placement, which were rotated
in the anticlockwise direction. Figures 6.3 and 6.4 show the same results as Figs. 6.1 and 6.2 but when the
electrodes are rotated 45 degrees in the clockwise direction. Even though the recovered traces are not
perfectly identical compared to the original, they retain all the diagnostic quality as the original according
to medical experts [14] . Furthermore, it is common for different PQRST signals to be slightly dissimilar
and not perfectly aligned due to the slight displacement of the heart from original location from beat to
beat (e.g., due to motion), and other factors. [1]
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Figure 6.2 Comparison of X and Y leads recorded with normal electrode placement and software
recovered leads (electrodes were rotated by 45 degrees in clockwise direction).

Figure 6.3 Reference heart vector, v projected in XY plane with electrodes in normal position (blue),
vector vr from electrodes rotated in clockwise direction by 45 degrees (red,) and software de-rotated
vector vs (black)
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Figure 6.4 Comparison of X and Y leads recorded with normal electrode placement and software
recovered leads (electrodes were rotated by 45 degrees in clockwise direction).
6.4.2 Search Method for Rotation

Figure 6.5 Reference heart vector, v projected in XY plane with electrodes in normal position (blue),
vector vr from electrodes rotated in anticlockwise direction by 45 degrees (red), software de-rotated
vector vs using the MMSE search technique (black)
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Figure 6.6 Reference heart vector, v projected in XY plane with electrodes in normal position (blue),
vector vr from electrodes rotated in anticlockwise direction by 45 degrees (red), software de-rotated
vector vs using the MMSE search technique (black)
We present an approach to determine the angle of rotation, θ and algorithmically correct the
distorted signal vr acquired from a disoriented iVCG device. At the time of installation of the iVCG
device, the reference heart vector, v can be recorded for N heartbeats at the correct orientation and
placement as judged by the physician. The angle of orientation can be determined by minimizing the
mean square error between the reference heart vector, v and the software de-rotated vector vs as shown
below.
The mean squared error (MSE) of the v and vs can be written as,
2

𝒊𝒊
𝒊𝒊
𝐸𝐸 = ∑𝑘𝑘𝑘𝑘
𝑖𝑖=1 �𝒗𝒗 − 𝒗𝒗𝒔𝒔 �

(6-5)

where, k is the number of samples in the heart beat and N is the number of heartbeats of the recorded
reference.
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Substituting the expression for vs from (1), the MSE is
2

𝒊𝒊
𝒊𝒊
𝐸𝐸 = ∑𝑘𝑘𝑁𝑁
𝑖𝑖=1 �𝒗𝒗 − 𝑅𝑅𝜃𝜃 𝒗𝒗𝒓𝒓 �

(6-6)

The value of θ that minimizes the value of E is regarded as an accurate estimate of the actual
angle of rotation and the original signal is then recovered using (6-3). The value can be ascertained by
iteratively searching in the range 0 and 360 degrees in small steps.
Figure 6.5 shows the reference heart vector v, anticlockwise-rotated vector vr and the corrected
clockwise-rotated vector vs using the above described method. Figure 6.6 shows a similar figure but for a
clockwise-rotated vector vr.
6.4.3 Analytical Approach
An analytical solution was also devised that does not involve iteratively searching for the correct
angle of rotation. The solution for the angle can directly found by using the following approach. Let x, y
and z be the X, Y, and Z components of the pre-recorded reference vector v, and let x’, y’ and z’ be the X,
Y and Z components of the rotated vector vr. Of course, x, y, z, x’ y’ and z’ are discrete time dependent
signals measured from the electrodes. The software corrected vector is called 𝐯𝐯𝐬𝐬. The rotation matrix is

represented by Rθ .

The reference vector v, the rotated vector vr and the software corrected vector vs can be
represented as column vectors with their respective X, Y and Z components.
𝒗𝒗 = [𝑥𝑥 𝑦𝑦 𝑧𝑧]𝑇𝑇

(6-7)

𝒗𝒗𝒔𝒔 = [𝑥𝑥𝑠𝑠 𝑦𝑦𝑠𝑠 𝑧𝑧𝑠𝑠 ]𝑇𝑇

(6-9)

𝒗𝒗𝒓𝒓 = [𝑥𝑥 ′ 𝑦𝑦 ′ 𝑧𝑧 ′ ]𝑇𝑇

We can write 𝐯𝐯𝐬𝐬 as,
According to (6-3), (6-4) and (6-8),

𝑥𝑥𝑠𝑠 = (𝑥𝑥 ′ 𝑐𝑐𝑐𝑐𝑐𝑐 𝜃𝜃 + 𝑦𝑦 ′ 𝑠𝑠𝑠𝑠𝑠𝑠 𝜃𝜃)

and

𝑑𝑑𝑥𝑥𝑠𝑠
𝑑𝑑𝑑𝑑

= (−𝑥𝑥 ′ 𝑠𝑠𝑠𝑠𝑠𝑠 𝜃𝜃 + 𝑦𝑦 ′ 𝑐𝑐𝑐𝑐𝑐𝑐 𝜃𝜃)
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(6-8)

(6-10)
(6-11)

𝑦𝑦𝑠𝑠 = (−𝑥𝑥 ′ 𝑠𝑠𝑠𝑠𝑠𝑠 𝜃𝜃 + 𝑦𝑦 ′ 𝑐𝑐𝑐𝑐𝑐𝑐 𝜃𝜃)

(6-12)

𝑧𝑧𝑠𝑠 = 𝑧𝑧′

(6-14)

𝑑𝑑𝑦𝑦𝑠𝑠
𝑑𝑑𝑑𝑑

and

= (−𝑥𝑥 ′ 𝑐𝑐𝑐𝑐𝑐𝑐 𝜃𝜃 − 𝑦𝑦 ′ 𝑠𝑠𝑠𝑠𝑠𝑠 𝜃𝜃)

𝑑𝑑𝑧𝑧𝑠𝑠
𝑑𝑑𝑑𝑑

We can rewrite the equation (6-5) as,

(6-13)

=0

(6-15)

2

2

2

𝑘𝑘𝑘𝑘
𝑘𝑘𝑘𝑘
𝑖𝑖
𝑖𝑖
𝑖𝑖
𝑖𝑖
𝑖𝑖
𝑖𝑖
𝑬𝑬 = ∑𝑘𝑘𝑘𝑘
𝑖𝑖=1�𝑥𝑥 − 𝑥𝑥𝑠𝑠 � + ∑𝑖𝑖=1�𝑦𝑦 − 𝑦𝑦𝑠𝑠 � + ∑𝑖𝑖=1�𝑧𝑧 − 𝑧𝑧𝑠𝑠 �

The correct value of 𝜃𝜃 minimizes the above equation. It follows that,
𝑑𝑑𝑑𝑑
𝑑𝑑𝑑𝑑

𝑖𝑖
𝑖𝑖
= ∑𝑘𝑘𝑘𝑘
𝑖𝑖=1 2�𝑥𝑥 − 𝑥𝑥𝑠𝑠 �

𝑑𝑑�𝑥𝑥 𝑖𝑖 −𝑥𝑥𝑠𝑠 𝑖𝑖 �

Substituting (6-10) – (6-15),

𝑑𝑑𝑑𝑑

𝑖𝑖
𝑖𝑖
+ ∑𝑘𝑘𝑘𝑘
𝑖𝑖=1 2 �𝑦𝑦 − 𝑦𝑦𝑠𝑠 �

𝑑𝑑�𝑦𝑦 𝑖𝑖 −𝑦𝑦𝑠𝑠 𝑖𝑖 �
𝑑𝑑𝑑𝑑

(6-16)

=0

(6-17)

𝑘𝑘𝑘𝑘

𝑖𝑖
𝑑𝑑𝑑𝑑
𝑖𝑖
𝑖𝑖
𝑖𝑖
𝑖𝑖
= � 2 �𝑥𝑥 𝑖𝑖 − �𝑥𝑥 ′ 𝑐𝑐𝑐𝑐𝑐𝑐 𝜃𝜃 + 𝑦𝑦 ′ 𝑠𝑠𝑠𝑠𝑠𝑠 𝜃𝜃� � �−𝑥𝑥 ′ 𝑠𝑠𝑠𝑠𝑠𝑠 𝜃𝜃 + 𝑦𝑦 ′ 𝑐𝑐𝑐𝑐𝑐𝑐 𝜃𝜃�
𝑑𝑑𝑑𝑑
𝑖𝑖=1

𝑘𝑘𝑘𝑘

𝑖𝑖

𝑖𝑖

𝑖𝑖

𝑖𝑖

+ � 2 �𝑦𝑦 𝑖𝑖 − �−𝑥𝑥 ′ 𝑠𝑠𝑠𝑠𝑠𝑠 𝜃𝜃 + 𝑦𝑦 ′ 𝑐𝑐𝑐𝑐𝑐𝑐 𝜃𝜃�� �−𝑥𝑥 ′ 𝑐𝑐𝑐𝑐𝑐𝑐 𝜃𝜃 − 𝑦𝑦 ′ 𝑠𝑠𝑠𝑠𝑠𝑠 𝜃𝜃� = 0
𝑖𝑖=1

(6-18)

By expanding and rearranging (6-18) we have
𝑖𝑖

𝑖𝑖

𝑖𝑖

𝑘𝑘𝑘𝑘 𝑖𝑖 ′
𝑘𝑘𝑘𝑘 𝑖𝑖 ′
𝑘𝑘𝑘𝑘 𝑖𝑖 ′
𝑖𝑖 ′
𝑠𝑠𝑠𝑠𝑠𝑠 𝜃𝜃 ∑𝑘𝑘𝑘𝑘
𝑖𝑖=1 𝑥𝑥 𝑥𝑥 − 𝑐𝑐𝑐𝑐𝑐𝑐 𝜃𝜃 ∑𝑖𝑖=1 𝑥𝑥 𝑦𝑦 + 𝑐𝑐𝑐𝑐𝑐𝑐 𝜃𝜃 ∑𝑖𝑖=1 𝑦𝑦 𝑥𝑥 + 𝑠𝑠𝑠𝑠𝑠𝑠 𝜃𝜃 ∑𝑖𝑖=1 𝑦𝑦 𝑦𝑦 = 0

𝑇𝑇𝑇𝑇𝑇𝑇 𝜃𝜃 =

𝑘𝑘𝑘𝑘 𝑖𝑖 𝑖𝑖
𝑖𝑖 𝑖𝑖
∑𝑘𝑘𝑘𝑘
𝑖𝑖=1 𝑥𝑥 𝑦𝑦𝑟𝑟 − ∑𝑖𝑖=1 𝑦𝑦 𝑥𝑥𝑟𝑟

𝑘𝑘𝑘𝑘 𝑖𝑖 𝑖𝑖
𝑖𝑖 𝑖𝑖
∑𝑘𝑘𝑘𝑘
𝑖𝑖=1 𝑦𝑦 𝑦𝑦𝑟𝑟 + ∑𝑖𝑖=1 𝑥𝑥 𝑥𝑥𝑟𝑟

(6-19)

(6-20)

The results obtained from this approach perfectly match with results from the previous approach.
That is, the unknown angle of rotation calculated by both methods was found to be equal.
6.4.4 Displacement Results
Figure 6.7 shows a representative normal X lead in blue and the displaced and recovered X lead
in red. After experiments, it was determined that the displaced lead can be recovered only when the signal
to noise ratio is good. This limits the zone of operation to the extremities of the chest area.
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Figure 6.7 Normal VCG lead vs VCG lead recovered from displaced location
6.5 Conclusion
This chapter demonstrates the approach to correct an inadvertently rotated and displaced iVCG
device completely in software without the patient’s involvement.
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CHAPTER 7. MACHINE LEARNING FOR PREDICTIVE ANALYTICS

7.1 Introduction
Atrial fibrillation is the most common type of cardiac arrhythmia. Patients with this condition,
suffer from ineffective conduction caused by erratic and irregular rhythm of the heart beat especially in
the atria. This increases the risk of embolic stroke, heart failure and increased fatigue. More than 2 million
people suffer from atrial fibrillation in the United States [69]. Atrial fibrillation can fall under three
categories: Paroxysmal, persistent or permanent based on the duration of the event. [70]
The iVCG is equipped to record cardiac signals from the heart for long periods of time. These
cardiac signals are said to be of full diagnostic quality. Significantly, this feature has never been
demonstrated before. Accumulating continuous heart signal recordings will better equip healthcare
providers to monitor patients remotely, help them avoid unnecessary hospital visits and also opens up the
possibility of developing algorithms tailored to each patient (i.e., personalized) to predict impending
cardiac events. Moreover, the mining of large scale data or ‘BIG DATA’ that is voluminous, as well as
rich in information (i.e., full diagnostic quality) can lead to various insights into the physiology of the
heart and solve various medical mysteries faced by cardiologists today. The storage and analysis of
individual patient data can also lead to personally tailored prediction and diagnosis. This is called
‘personalized medicine.’ [71]–[73]
For instance, Lindsberg et al., [74] indicate the need for long-term monitoring for detecting
paroxysmal AF, and the need for automated event detection, especially if episodes are asymptomatic.
In this chapter, we present a patient specific approach to predict the occurrence of impending
episodes of AF using Support Vector Machines (SVM) and Neural Networks (NN) [75]. This work has
been published in [75].
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7.2 Literature Survey
The Computers in Cardiology Challenge 2001 was created to encourage research into predicting
the onset of AF [9]. One of the underlying clinical objectives was to help develop technology that could
possibly stabilize a patient’s normal sinus rhythm and prevent the onset of an AF episode with different
pacing mechanisms.
In this section we review some of the literature describing entries to the Computers in Cardiology
Challenge 2001 to predict the onset of AF. There were 28 pairs of ECGs in the test set and scores were
calculated as a percentage of the number of correctly classified pairs. Lynn and Chiang [76] used statespace domain features of heart rate variability (HRV). They classified return and difference maps using knearest neighbors and scored 64% in predicting AF onset. Zong et al. [77] used the number of isolated
premature atrial complexes (PACs) appearing in ECGs modified with a weight to favor complexes that
had most recently occurred to predict AF episodes. Their rule-based classifier scored 79%. Langley et al.
[78] extracted features based on the frequency of ectopic beat occurrence in RR-intervals. A moving
average of the RR-intervals was maintained and an ectopic beat was flagged if an interval under
consideration was less than 20% of the average. They predicted the onset of AF by counting the number
of atrial and ventricular ectopic beats and obtained a score of 61%. Schreier et al. [79] applied beat
classification to the ECG signals and extracted regular and premature heartbeats. They calculated the
correlation between a representative template of the p-wave in either group with those extracted from test
signals. Diagnosis was performed using a statistical test and they scored 71% in the prediction problem
where a weighted measure of the correlation coefficients was used. De Chazal and Heneghan [80]
developed a number of features and used Linear Discriminant Analysis for classification. The types of
features they used included time and frequency domain features of RR-intervals, features extracted from
p-wave amplitudes and the frequency content of p-waves. Their proposed method received 68% on the
prediction challenge. Maier et al. [81] used features extracted from RR-intervals and the number of
ectopic beats and evaluated different classification approaches. Their entries to the contest received a
score of 68%.
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Thong et al. [82] revisited the original challenge and proposed a predictor based on the number of
PACs not followed by a regular RR-interval, the occurrence of atrial bigeminy and trigeminy rhythms and
the appearance of short durations of paroxysmal atrial tachycardia. Their rule-based system scored 89%
outperforming [77] that had scored highest in the 2001 contest. It must be noted that these authors and
subsequent researchers had access to additional data that the original competitors did not. More recently,
Hilavin and Kuntalp [83] used complex correlation measures of HRV and obtained a score of 72% on the
same dataset. Chesnokov et al. [84] trained a neural network to distinguish between distant and pre-AF
records using the power spectral density of HRV signals and obtained a sensitivity of 72.7% on test data.
Arotaritei and Rotariu [70] considered the appearance of successive PACs, the Teager entropy and root
mean square of successive differences in RR-intervals and achieved a sensitivity of 52%.
In a study of Holter recordings seeking to determine if paroxysmal AF had a common mode of
initiation in all patients, Hnatkova et al. [85] concluded that there was no consistent mode of AF onset
across a population having the arrhythmia and even within an individual. They claim that “there is
marked variation in the rate and rhythm before onset not only between patients, but also between episodes
of AF in an individual patient, and no clearly identifiable pattern was seen.” Their conclusions caused us
to seek to develop patient specific classification models instead of global classifiers that could predict AF
onset for everyone.
7.3 Comparison between SVMs and NNs
Support Vector Machines (SVM) are used in machine learning in order to differentiate between
multiple classes of data using hyperplanes [86]. The hyperplane is chosen based on a few specific
instances in the data set that are sufficient to describe the hyperplane. These are called support vectors.
The objective is to maximize the margin between classes. The data is analyzed and meaningful features
are extracted and used for classification [87].
A neural network is a network of neurons that are used to learn patterns in input data and make
decisions based on those patterns, as explained in detail in Chapter 2.
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Given a classification problem, the SVM results tend to be easily interpretable and useful in
providing meaningful insights. The SVMs are easy to implement and computationally inexpensive as they
need not use the entire data set, only the support vectors. The disadvantage of SVMs is that features need
to be manually extracted from the data set. This may involve spending significant time in the
preprocessing step of the classification task. SVMs are preferred when interpretability is desired. An
example is where, the problem of minimizing default rate on bank loans by learning to choose the correct
applicants based on profile like yearly income, mortgage etc.
Neural networks on the other hand do not typically require that the data to be preprocessed in the
same scale as with SVMs. The data can usually be input to the network without being modified much,
unless the dimensionality of the data is high compared to the amount of data available. The neural
network need not be changed much if more inputs are to be added. Neural networks are more desired
when there is a lot of data and the task to be learned is complex, as is the case in deep learning
applications. The drawback of neural networks is that they are computationally expensive and have a
tendency to overfit. An example where neural networks may be preferred over SVMs is the classification
is automatic speech recognition (ASR) since the task to be learnt is quite complex and the neural network
may have to differentiate between tone, context etc., in speech. [88]
7.4 Patient Specific Prediction of Paroxysmal Atrial Fibrillation (PAF) with Support Vector
Machines (SVM)
7.4.1 Data
The Long-Term Atrial Fibrillation Database (LTAFDB) from PhysioBank [89] contains 84 ECG
recordings from patients with sustained or paroxysmal AF. Each recording is approximately 24 hours in
duration and contains two ECG signals recorded at a sampling frequency of 256 Hz. The algorithm that
we build needs to recognize ECGs that occurred shortly before the commencement of episodes of AF and
distinguish them from ECG signals that are far away from such abnormal rhythms (which are assumed to
be normal ECGs). For each patient, hundred ECG epochs were randomly selected, each being 2 minutes
in duration, from every record, located at least 10 minutes away from an AF rhythm and labeled this
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collection of ECGs as the normal (or distant set). Thereafter, we selected ECG epochs of identical
duration from the same records but which terminate 0, 1, 2 and 3 minutes respectively, prior to the start of
each episode of AF and labeled it as the pre-atrial fibrillation (pre-AF) set. If an epoch contains another
AF episode it is discarded. We only selected recordings containing at least 20 episodes of AF in order to
have enough data for both classes to train patient specific models. Hence we had to train four classifiers
corresponding to data for four different measures marking the time to AF event as stated above. We call
this the ‘prediction horizons’.
7.4.2 Feature Extraction
Eight statistics were chosen to capture the variations in heart rate during each epoch. Outliers
were defined as the points greater than three standard deviations away from zero. The number of outliers
along with their maximum, minimum, mean and median of the heart rate, were the first five statistics. The
median and root mean square value of the series without the outliers were also extracted. The final feature
was the number of data points in the series that is equivalent to the number of heartbeats during the epoch.

Figure 7.1 Feature distribution of distant and pre-AF data points for patient/record 33 for 0-minute
prediction horizon
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Autoregressive (AR) modeling [90] was performed and four AR coefficients were extracted to
capture the variation within the RR-interval time series. We also chose as features, the number of
individual abnormal beats or ectopic beats (such as premature atrial contraction, premature ventricular
contraction etc.,) occurring in the two minute epoch. When concatenated, all of the above attributes form
a feature vector with 27 values corresponding to each 2-minute ECG.

Figure 7.2 Feature distribution of distant and pre-AF data points for patient/record 51 for 1-minute
prediction horizon
7.4.3 Classification
We used Support Vector machine (SVM) and used the LibSVM package in Weka [21] with 10fold cross-validation. We calculated sensitivity, specificity and overall accuracy for each of the four
classifiers trained per patient. Sensitivity measures the ratio between the number of correctly predicted
data points belonging to the pre-AF class and the actual number of data points belonging to that class.
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Specificity is a similar measure but is calculated for data points belonging to the distant class. The overall
accuracy is the percentage of the total number of correct predictions.
In total, four separate classifiers were trained for each patient. The time between the end of an
ECG epoch and the commencement of a fibrillatory rhythm, (being either 0, 1, 2 or 3 minutes) is called
the ‘prediction horizon.’ Principal Component Analysis (PCA) was performed using the highest
eigenvalues of the feature covariance matrix to project the data onto a lower dimensional subspace using
the corresponding eigenvectors, for visualization. The Principal Components (PCs) are linear
combinations of the features and have no physical interpretation by themselves. Feature distributions for
two different representative patients for different prediction horizons projected onto the first two Principal
Components have been shown in Figure 7.1 and Figure 7.2.
7.4.4 Results with SVM
Sensitivity is above 85% for almost all patients when the SVM performs classification between
ECGs that terminate right at an AF episode (i.e., the prediction horizon is 0 seconds) and ECGs belonging
to the distant class. Sensitivity tends to drop on average as the prediction horizon increases and ECGs
further away from the episode make up the pre-AF class. It is likely that as we move further away from
fibrillatory rhythms, RR-intervals and ectopic beats do not contain much information regarding an
impending abnormal rhythm. Furthermore, features belonging to both classes projected onto the first two
principal components gradually begin to overlap as the prediction horizon increases.
In the next section, we perform prediction of AF events using neural networks. In this experiment
we do not use extracted features but rather a modified record of the time series ECG information.
7.5 Patient Specific Prediction of Paroxysmal Atrial Fibrillation (PAF) with Neural Networks (NN)
A neural network (NN) was evaluated as a solution to the problem of predicting PAF in patients.
ECG time series signals pose problems as inputs to the NN due to their high dimensionality even after
appropriate down-sampling. Two minutes of ECG data at a down sampled rate of 128 Hz equals 15360
samples. When these samples are input to the neural network there is a large number of weights in the
input layer to be trained. This is especially disadvantageous considering that for patient specific models
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we have fewer events to train with. The challenge then is to devise a preprocessing step to input the ECG
information to the neural network in such a way that the dimensionality is reduced and at the same time
the relevant information that allows the differentiation of both classes, is preserved.
7.5.1 Preprocessing Step
The heart rate is captured by measuring the interval between successive R peaks of the PQRST
wave shape in the ECG. This is called the RR interval. When a patient is about to undergo PAF, their
heart rate experiences fluctuations, going from very fast to slow in a random fashion. Hence the most
relevant information while predicting PAF is the RR interval variability.

Figure 7.3 NN architecture with 30 hidden neurons and 90 inputs
A window of fixed length was chosen and moved across the two minute epoch. The number of
RR peaks occurring in the window was counted at each step. If there was no RR peak, ‘0’ was inserted.
The number of RR peaks for each observation was considered to be an input to the NN. By this process
the input vector length was 90, which is a more manageable input size.
This step is different from the dimensional reduction done in the SVM classification. The most
important distinction is that in this step we preserve to some extent, the temporal relationship between the
varying RR intervals in the epoch whereas in the SVM classification problem, features based on the entire
time series data are condensed into certain significant values 2, which do not readily show temporal

2

For example, the mean HR, max HR, min HR, and/or number of premature ventricular contractions etc.
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dependencies. For example, one of the features of the SVM is number of premature ventricular
contractions in the epoch (PVC).
The preprocessing step was performed for all epochs in the ‘distant’ data set as well as the ‘preAF’ set. The data set was split such that 70% was used for training and 30 % was used for testing. The
neural network was designed with 30 hidden neurons and one hidden layer. The input vectors were fed
into the neural network and the weights were trained. Figure 7.3 below shows the architecture of the
neural network.

Figure 7.4 Accuracy of NN for prediction horizon of ‘0’ minutes. Class 0 = ‘distant’ and Class 1 =‘PreAF’

Figure 7.5 Accuracy of NN for prediction horizon of ‘2’ minutes. Class 0 = ‘distant’ and Class 1 =‘PreAF’
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7.5.2 Results with Neural Networks
Using this NN architecture mentioned previously we were able to get high accuracy, particularly
for a prediction horizon of 0 seconds. Near perfect accuracy (>98%) and a 100% area under the Receiver
Operator Characteristics (ROC) was achieved. A modest decrease in accuracy was observed as prediction
horizon moved farther away from the PAF event. This is shown in Figures 7.4 and 7.5 for a representative
patient.
7.6 Conclusion
In this chapter, we have presented our research in predictive analysis mainly to predict
paroxysmal atrial fibrillation (PAF). We have used two methods to this end: 1) a classical machine
learning approach where we manually analyzed the data and extracted meaningful features and trained an
SVM, and 2) a neural network approach with preprocessed ECG time series data.
Both methods have their advantages. The SVM results are easily interpretable and useful in
providing meaningful insights about pre-AF behavior to physicians while the neural network approach
can be used in the future as a framework for multiple sensory inputs and for deep learning applications.
Both were successful in showing good accuracy in predicting PAF.
This work shows the potential of machine learning and long term (“big”) data to predict heart
conditions in patients. The next steps should be to leverage more long term cardiac data to predict more
serious heart conditions such as heart attacks and ventricular fibrillation.
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CHAPTER 8. CONCLUSIONS AND FUTURE DIRECTION

8.1 Main Contributions and Conclusions
This dissertation presents the integrated vectorcardiogram (iVCG) system, which allows remote,
long-term, continuous, unobtrusive, full-diagnostic quality cardiac monitoring for patients. This capability
has not been achieved before.
State of the art remote cardiac monitoring technology is limited in the amount of information it
provides and this in turn limits its diagnostic capability. It is estimated that around 17 million people in
the world die from cardiac related events each year. It is reasonable to expect, that this number can be
significantly reduced by improving the quantity and quality of information that can be monitored
remotely and continuously.
The 12-lead ECG is the ‘gold standard’ of cardiac monitoring in the medical industry. Ten
electrodes placed in strategic locations record 12 signals or ‘leads’ that comprehensively describe the
electric activity of the heart in all 3 dimensions. Consequently, abundant information about the health of
the heart and its conduction system is provided to a trained physician. Unfortunately due to its bulky form
and obstructive number of wires it is not suitable for portable or ‘ambulatory’ monitoring. The
vectorcardiogram (VCG), which is an equally viable but outmoded technology, contains the same amount
of information as the 12-lead ECG. The VCG records the 3-dimensional heart vector by measuring the
three leads: referred to as X, Y and Z.
In this dissertation, a method to miniaturize the VCG and integrate its electrodes so that they can
fit inside a 3x3x2 cm device has been described. This is dubbed the iVCG and it has a form factor that is
small enough to be unobtrusive to the patient but can provide as much information to physicians as the
12-lead ECG or the conventional VCG.
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In Chapter 4 we have described the experiments performed to shorten the inter-lead distance
required to support a small unobtrusive device. The inter-lead distance was brought down as low as 2 cm
in the X and Y directions.
While the iVCG provides as much information as the 12-lead ECG it is in a different format and
is not readily intelligible to a physician. In Chapter 5, we have presented a solution to this problem based
on the linear least-squares method. Using this method the iVCG signals can be converted to the 12-lead
ECG format for viewing by the physician.
Since it is an integrated device removed of all lead redundancy, the iVCG device is sensitive to
placement. The device will be placed on patients by a trained technician or physician. In Chapter 6, we
have presented an analytical and iterative solution to correct for inadvertent misplacement of the iVCG by
the patient or due to general wear and tear.
Using machine learning, specifically neural networks, we have shown some preliminary results in
Chapter 3 relating to diagnosis of heart conditions. We achieved near perfect accuracy in diagnosing atrial
flutter and atrial fibrillation. This method can be used for some ambulatory wireless ECGs (less than
diagnostic quality) devices as well.
In Chapter 7, we presented our research in predictive analytics. Some interesting results are
presented that show that certain heart conditions can be predicted with good accuracy. Long-term ECG
records of patients suffering with paroxysmal atrial flutter (PAF) where analyzed and a model was built,
which accurately predicted PAF in patients using time series data from up to 4 minutes before the event
using SVMs and neural networks.
8.2 Future Directions
This dissertation presented the successful working of a research platform that proves that full
diagnostic quality information can be recorded by a small portable heart-monitoring device. The next step
is to design a prototype based on this work in the anticipated form factor and with the associated
functionality.
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The prototype must include both Personal Area Network (PAN) and Local Area Network (LAN)
communication capability. For example, it should communicate with a cell phone and connect to Wi-Fi. It
should also have a cellular connection for delivery of emergency notifications when PAN/LAN
communication is not possible.
The device must be able to communicate recorded cardiac signals to a hospital server and do so
judicially in order to conserve battery power. Two possible solutions are 1) having an on board memory
that stores signals and transmits during night time, 2) using compression techniques such as compressive
sensing [91] etc., to decrease the amount of transmitted data. The device also needs to be installed with
the latest expert system software that is able to detect all abnormalities that require immediate attention.
The iVCG device is also envisioned as a platform for various sensory devices. For example, the
iVCG device may communicate with a glucose pump, pacemaker or other lifestyle devices and perform
data fusion with the end goal of improving diagnoses and patient outcomes.
One interesting future application will be the mining of long term full-diagnostic quality Big
Data. Due to the physical limitations of the 12-lead ECG, the longest available records are few and not
very long (24-48 hours). With the iVCG device, we will have the opportunity to analyze truly ‘long-term’
records (weeks and months). It will be interesting to see the new information that can be mined by
applying machine learning to this data. The user-end application is that the machine diagnosis software on
the device can be constantly updated based on the new insights learned from the big data analysis to
improve the quality and scope of diagnosis.
Another exciting application is the development of predictive analytics based on the recorded
data. Deep learning methods may be used to analyze data from the iVCG device and other sensory
sources to detect trends and identify precursors to life threatening heart events such as myocardial
infarction and ventricular fibrillation. The device can alert users to these impending heart events and
direct them to a hospital or to appropriate action. As mentioned earlier, an example of this analysis is
shown in this dissertation where predictive trends for patients who suffered from paroxysmal atrial
fibrillation were identified.
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